Literature DB >> 12940781

Hormone receptors in non-malignant meningiomas correlate with apoptosis, cell proliferation and recurrence-free survival.

A E Konstantinidou1, P Korkolopoulou, H Mahera, X Kotsiakis, S Hranioti, C Eftychiadis, E Patsouris.   

Abstract

AIMS: A retrospective immunohistochemical and statistical analysis of patients with non-malignant meningiomas was undertaken to determine the correlation of steroid hormone receptor status with apoptosis, tumour cell proliferation, clinicopathological characteristics and prediction of recurrence. METHODS AND
RESULTS: Paraffin sections from 51 primary intracranial totally resected benign and atypical meningiomas were immunohistochemically evaluated for the expression of progesterone (PR), oestrogen (ER) and androgen (AR) receptors, apoptotic rate, Bcl-2, p53 and Ki67 antigens. In addition to the above parameters, the mitotic index and the patients' clinicopathological data were statistically correlated and entered in a recurrence-free survival analysis. A high level of apoptotic cell death was associated with loss of PR expression by logistic regression analysis (P = 0.016). An inverse correlation existed between the mitotic index and PR counts (P = 0.009), while high Ki67 values correlated with increased ARs (P = 0.041). Atypical meningiomas had a lower ER staining score (P = 0.036). Multivariate analysis indicated that the absence of PR and large tumour size were significant factors for shorter disease-free intervals.
CONCLUSIONS: The results suggest that ER expression is lost or reduced in atypical meningiomas, whereas loss of PR expression is an indicator of increased apoptosis and early recurrence. PRs and ARs may also influence tumour cell proliferation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12940781     DOI: 10.1046/j.1365-2559.2003.01712.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  13 in total

1.  Recurrences of meningiomas: predictive value of pathological features and hormonal and growth factors.

Authors:  Francesco Maiuri; Marialaura Del Basso De Caro; Felice Esposito; Paolo Cappabianca; Viviana Strazzullo; Guido Pettinato; Enrico de Divitiis
Journal:  J Neurooncol       Date:  2007-01-17       Impact factor: 4.130

2.  Identification of epithelial membrane protein 2 (EMP2) as a molecular marker and correlate for angiogenesis in meningioma.

Authors:  Kunal S Patel; Sameer Kejriwal; Michel M Sun; Samasuk Thammachantha; Courtney Duong; Ann Chan; Nina Cherian; Prasanth Romiyo; Lynn K Gordon; William Yong; Madhuri Wadehra; Isaac Yang
Journal:  J Neurooncol       Date:  2020-01-24       Impact factor: 4.130

3.  Complex interactions between the components of the PI3K/AKT/mTOR pathway, and with components of MAPK, JAK/STAT and Notch-1 pathways, indicate their involvement in meningioma development.

Authors:  Elias A El-Habr; Georgia Levidou; Eleni-Andriana Trigka; Joanna Sakalidou; Christina Piperi; Ilenia Chatziandreou; Anastasia Spyropoulou; Rigas Soldatos; Georgia Tomara; Kalliopi Petraki; Vassilis Samaras; Athanasios Zisakis; Vassilis Varsos; George Vrettakos; Efstathios Boviatsis; Efstratios Patsouris; Angelica A Saetta; Penelope Korkolopoulou
Journal:  Virchows Arch       Date:  2014-08-22       Impact factor: 4.064

Review 4.  Molecular pathogenesis of meningiomas.

Authors:  Arie Perry; David H Gutmann; Guido Reifenberger
Journal:  J Neurooncol       Date:  2004-11       Impact factor: 4.130

5.  Female predominance in meningiomas can not be explained by differences in progesterone, estrogen, or androgen receptor expression.

Authors:  Katariina Korhonen; Tiina Salminen; Jani Raitanen; Anssi Auvinen; Jorma Isola; Hannu Haapasalo
Journal:  J Neurooncol       Date:  2006-05-13       Impact factor: 4.130

6.  Fatty acid synthase as a novel target for meningioma therapy.

Authors:  Daniela Haase; Stefan Schmidl; Christian Ewald; Rolf Kalff; Christian Huebner; Raimund Firsching; Gerburg Keilhoff; Matthias Evert; Werner Paulus; David H Gutmann; Anita Lal; Christian Mawrin
Journal:  Neuro Oncol       Date:  2010-02-05       Impact factor: 12.300

7.  Meningioma and breast cancer: survival of patients with synchronous and metachronous meningioma and breast cancer.

Authors:  José Pedro Lavrador; Marta Valente Pinto; Luís Mascarenhas Lemos; Catarina Ribeiro; André Peralta Santos
Journal:  J Neurooncol       Date:  2017-11-08       Impact factor: 4.130

8.  Expression of cell adhesion proteins and proteins related to angiogenesis and fatty acid metabolism in benign, atypical, and anaplastic meningiomas.

Authors:  Alexandros Theodoros Panagopoulos; Carmen Lucia Penteado Lancellotti; José Carlos Esteves Veiga; Paulo Henrique Pires de Aguiar; Alison Colquhoun
Journal:  J Neurooncol       Date:  2008-04-17       Impact factor: 4.130

9.  Antigen expression on recurrent meningioma cells.

Authors:  Andrej Vranic
Journal:  Radiol Oncol       Date:  2010-05-24       Impact factor: 2.991

10.  Caspase-3 and survivin expression in primary atypical and malignant meningiomas.

Authors:  Andrej Vranic
Journal:  ISRN Neurosci       Date:  2013-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.